关注
Abdulrahman A Alsuhibani
Abdulrahman A Alsuhibani
其他姓名Abdulrahman Abdullah Alsuhibani, Pharm.D., M.Sc., Ph.D.
在 qu.edu.sa 的电子邮件经过验证
标题
引用次数
引用次数
年份
Descriptive analysis of reported adverse events associated with anti-obesity medications using FDA Adverse Event Reporting System (FAERS) databases 2013–2020
A Alsuhibani, M Alrasheed, M Gari, AL Hincapie, JJ Guo
International Journal of Clinical Pharmacy, 1-8, 2022
52022
Evaluation of statin discontinuation stratified by primary versus secondary prevention following bariatric surgery: a retrospective cohort study
A Alsuhibani, Y Albogami, V Diaby, J Friedman, SM Vouri
Surgery for Obesity and Related Diseases 17 (5), 939-946, 2021
42021
Metabolic and bariatric surgery utilization trends in the united states: evidence from 2012 to 2021 National Electronic Medical Records Network
A Alsuhibani, JR Thompson, PR Wigle, JJ Guo, AC Lin, MB Rao, ...
Annals of Surgery Open 4 (4), e317, 2023
32023
Changes in utilization of immediate-release, extended-release, and liquid formulation medications relative to bariatric surgery: a segmented regression analysis
SM Vouri, H Bhagwandass, IL Valdes, J Al-Bahou, A Alsuhibani, ...
Surgery for Obesity and Related Diseases 17 (6), 1089-1094, 2021
32021
Safety evaluation of panobinostat, ixazomib, elotuzumab, and daratumumab using FDA adverse event reporting system (FAERS) database 2015-2020
M Alrasheed, A Alsuhibani, AL Hincapie, J Guo
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 30, 333-333, 2021
12021
Comparison of quality of life between men and women with chronic liver diseases using chronic liver disease questionnaire (CLDQ): A meta-analysis
M Alrasheed, A Alsuhibani, AL Hincapie, J Welge
Pharmacoepidemiology and Drug Safety 30, 181-181, 2021
12021
Descriptive Analysis of Adverse Events Reported for New Multiple Myeloma Medications Using FDA Adverse Event Reporting System (FAERS) Databases from 2015 to 2022
MA Alrasheed, KA Alamer, M Albishi, AA Alsuhibani, OA Almohammed, ...
Pharmaceuticals 17 (7), 815, 2024
2024
A risk stratification analysis of ASCVD events post-statin discontinuation in patients who underwent sleeve gastrectomy or Roux-en-Y gastric bypass bariatric/metabolic surgeries
AA Alsuhibani, A Al-Kadi, PR Wigle, JJ Guo, AC Lin, MB Rao, ...
Surgery, 2024
2024
EPH160 A Risk Stratification Analysis of ASCVD Events Post-Statin Discontinuation in Bariatric Surgery Patients
A Alsuhibani, JJ Guo, AL Hincapie
Value in Health 27 (6), S181-S182, 2024
2024
Pharmacy students’ interprofessional experience and performance in advanced pharmacy practice experience rotations amid COVID-19 pandemic
M Alrasheed, A Alsuhibani, W Alotaibi, M Gari, A Alashgar, M Doherty, ...
Frontiers in Medicine 11, 1394652, 2024
2024
Factors Associated with Statin Discontinuation Following Metabolic and Bariatric Surgery: A Retrospective Analysis of 2012–2021 Electronic Medical Records Network Data
AA Alsuhibani, OA Al-Obeed, PR Wigle, MM Alsultan, JJ Guo, AC Lin, ...
Obesity Surgery 34 (4), 1267-1278, 2024
2024
Metabolic and Bariatric Surgery: Utilization, Statin Discontinuation, and Cardiovascular Risk Stratification in the Modern Era
A Alsuhibani
University of Cincinnati, 2024
2024
Utilization, reimbursement, and price trends for Hepatitis C virus medications in the US Medicaid programs: 2001–2021
MH Gari, A Alsuhibani, A Alashgar, JJ Guo
Exploratory Research in Clinical and Social Pharmacy 12, 100383, 2023
2023
Drug Expenditure, Price, and Utilization in US Medicaid: A Trend Analysis for New Multiple Myeloma Medications from 2016 to 2022
M Alrasheed, A Alsuhibani, B Balkhi, JJ Guo
Healthcare 11 (16), 2265, 2023
2023
EPH57 Trends in Utilization, Spending, and Prices of Anti-Obesity Medications in Medicaid Programs: 22 Years Empirical Data Analysis, 1999-2021
A Alsuhibani, JJ Guo
Value in Health 26 (6), S174, 2023
2023
EE20 Utilization, Reimbursements and Prices Trends of Hepatitis C Virus Drugs in the US Medicaid Programs from 2001 to 2021
M Gari, A Alsuhibani, A Alashgar, JJ Guo
Value in Health 26 (6), S63, 2023
2023
CO189 Metabolic and Bariatric Surgery Utilization Trends in the United States: Evidence from 2012–2021 National Electronic Medical Records Data
A Alsuhibani, JR Thompson, PR Wigle, JJ Guo, A Lin, MB Rao, ...
Value in Health 26 (6), S50, 2023
2023
School Poster Abstracts Presented at the 123rd Annual Meeting of the American Association of Colleges of Pharmacy, July 23-27, 2022
American Association of Colleges of Pharmacy
American Journal of Pharmaceutical Education 86 (5), 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–18